Ambroxol 30 mg + Guaifenesin 50 mg + Salbutamol 2 mg Tablet – Manufacturer, Supplier & PCD Franchise
Ambroxol 30 mg + Guaifenesin 50 mg + Salbutamol 2 mg Tablet
Ambroxol 30 mg + Guaifenesin 50 mg + Salbutamol 2 mg — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing
Form: Tablet
Class: mucolytic expectorant + expectorant + beta-2 agonist bronchodilator
✓ Pan-India Monopoly PCD
✓ Available Now
Pricing, brochure & monopoly territory within 24 hrs.
Ambroxol 30 mg + Guaifenesin 50 mg + Salbutamol 2 mg Tablet is available from Trumac Healthcare, a PCD pharma franchise company and supplier in India whose products are made at WHO-GMP certified partner units. This tablet formulation is offered on monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing basis across all Indian states. We already supply Ambroxol, Guaifenesin, Salbutamol across our existing range, so supply is established and lead times are short.
Therapeutic Indications
- The combination is used as the prescribing doctor decides; what each ingredient is used for:
- Ambroxol (mucolytic expectorant): Productive cough with thick, sticky mucus; Acute and chronic bronchitis as add-on therapy
- Guaifenesin (expectorant): Productive (wet) cough with thick mucus; Chest congestion in colds and bronchitis
- Salbutamol (beta-2 agonist bronchodilator): Bronchial asthma; Bronchospasm in chronic bronchitis and COPD
Mechanism of Action
Ambroxol: Stimulates production of thinner serous mucus and surfactant and enhances ciliary clearance, making phlegm less viscous and easier to cough out.
Guaifenesin: Guaifenesin increases the volume and reduces the stickiness of respiratory secretions. Loosened mucus is cleared more easily by coughing, making cough more productive.
Salbutamol: Stimulates beta-2 receptors in bronchial smooth muscle, raising cyclic AMP and relaxing the airways to relieve wheeze and breathlessness.
Dosage & Administration
- Dosage of Ambroxol 30 mg + Guaifenesin 50 mg + Salbutamol 2 mg Tablet must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
- Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
- Do not exceed the prescribed dose, and complete the full course as advised.
- Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
- To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
- Nausea
- Indigestion or abdominal discomfort
- Taste disturbance
- Nausea and vomiting
- Stomach upset
- Dizziness or drowsiness
- Tremor
- Palpitations and tachycardia
- Report any unexpected symptom to the prescribing doctor
Contraindications & Precautions
- Known hypersensitivity to any ingredient of the formulation
- Peptic ulcer disease
- Pregnancy, especially first trimester, and breastfeeding
- Persistent cough, or cough with fever or rash: seek advice
- Young children: avoid cough-cold combinations unless prescribed
- Hyperthyroidism and cardiovascular disease
- Diabetes; monitor blood glucose
Storage
Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.
Offered by Trumac Healthcare, a PCD pharma franchise company, available on a monopoly basis – see the respiratory and ENT pharma franchise product list (PDF). See our full tablet range for PCD franchise. Comparing companies? See the respiratory PCD companies compared. No franchise fee; minimum first order ₹25,000 – cost and documents.
See the full anti-allergy, cough & cold range – manufacturer, supplier and PCD franchise: cetirizine, levocetirizine, fexofenadine, bilastine, montelukast, cough syrups, cold tablets and acebrophylline.
PCD Pharma Franchise & Third Party Manufacturing — Ambroxol + Guaifenesin + Salbutamol Tablet
- ✓ Made at WHO-GMP certified partner units — every batch QC released
- ✓ Monopoly PCD franchise rights at district or state level
- ✓ Third party / contract manufacturing under your own brand
- ✓ Wholesale and distributor supply against drug licence + GST
- ✓ Attractive net rates with healthy PTR / PTS margins
- ✓ Dispatch within 48 hours of payment realisation
Composition: Ambroxol 30 mg + Guaifenesin 50 mg + Salbutamol 2 mg. Trumac Healthcare supplies this prescription pharmaceutical formulation with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.
PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Ambroxol + Guaifenesin + Salbutamol Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.
Frequently Asked Questions
Who manufactures Ambroxol + Guaifenesin + Salbutamol Tablet in India?
Trumac Healthcare is a supplier of Ambroxol + Guaifenesin + Salbutamol Tablet in India; products are made at WHO-GMP certified partner units. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.
Is Ambroxol + Guaifenesin + Salbutamol Tablet available for PCD pharma franchise on monopoly basis?
Yes. Ambroxol 30 mg + Guaifenesin 50 mg + Salbutamol 2 mg Tablet is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.
Do you offer Ambroxol + Guaifenesin + Salbutamol for third party or contract manufacturing?
Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Ambroxol + Guaifenesin + Salbutamol Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.
Can Ambroxol + Guaifenesin + Salbutamol Tablet be supplied on wholesale or distributor basis?
Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.
What is the therapeutic class of Ambroxol + Guaifenesin + Salbutamol?
Ambroxol + Guaifenesin + Salbutamol combines Ambroxol (mucolytic expectorant), Guaifenesin (expectorant) and Salbutamol (beta-2 agonist bronchodilator).
What documentation is provided with each supply?
Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.
How quickly can an order be dispatched?
Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.
Is a prescription required for Ambroxol + Guaifenesin + Salbutamol Tablet?
Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.
Ready to start your PCD franchise for Ambroxol 30 mg + Guaifenesin 50 mg + Salbutamol 2 mg Tablet?
